Cara Therapeutics, Inc. (NASDAQ: CARA) today announced that it has commenced an underwritten public offering of 4,500,000 shares of its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

Cara Therapeutics (CARA), Entris BioPharma Inc. Report Dosing of First Patient in Phase 2 Trial of Peptelligence-Engineered Oral KORSUVAJuly 19, 2018 8:06 AM Cara Therapeutics (CARA) Prices 4.5M Share Common Offering at $19/ShJuly 19, 2018 5:49 AM Cara Therapeutics Announces Proposed Offering of Common StockJuly 17, 2018 4:22 PM